Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,756
Closed -$6.95M 4120
2026
Q1
$6.95M Buy
+19,756
New +$7.04M 0.12% 159
2025
Q3
Sell
-10,774
Closed -$3.01M 2521
2025
Q2
$3.01M Buy
10,774
+5,647
+110% +$1.6M 0.12% 190
2025
Q1
$1.6M Buy
5,127
+2,782
+119% +$822K 0.08% 332
2024
Q4
$611K Sell
2,345
-3,557
-60% -$1.06M 0.05% 600
2024
Q3
$1.9M Buy
5,902
+3,787
+179% +$1.24M 0.14% 159
2024
Q2
$661K Buy
+2,115
New +$621K 0.06% 523
2024
Q1
Sell
-983
Closed -$283K 1797
2023
Q4
$283K Buy
983
+60
+7% +$16.3K 0.06% 673
2023
Q3
$248K Sell
923
-7,847
-89% -$1.96M 0.04% 865
2023
Q2
$1.95M Buy
+8,770
New +$2.03M 0.35% 9
2023
Q1
Sell
-5,758
Closed -$1.51M 1246
2022
Q4
$1.51M Buy
+5,758
New +$1.54M 0.32% 28
2022
Q3
Sell
-9,956
Closed -$2.42M 1083
2022
Q2
$2.42M Buy
+9,956
New +$2.44M 0.99% 2
2022
Q1
Sell
-1,471
Closed -$331K 656
2021
Q4
$331K Sell
1,471
-81
-5% -$17.1K 0.19% 162
2021
Q3
$330K Buy
+1,552
New +$357K 0.11% 313
2021
Q2
Sell
-907
Closed -$226K 785
2021
Q1
$226K Buy
+907
New +$216K 0.11% 434

Other funds holding AMGN

XTX Topco's AMGN Position: Q2 2026 in Review

XTX Topco sold out of Amgen (AMGN) in Q2 2026, closing a stake of 19,756 shares — an estimated $6.95M sold.

XTX Topco first reported a position in AMGN in Q1 2021 and held it in 14 quarters. The position peaked at $6.95M in Q1 2026. 3,150 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • XTX Topco reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 19,756 Amgen shares in Q2 2026, an estimated $6.95M.
  • XTX Topco first reported a position in Amgen in Q1 2021 and held it in 14 quarters.
  • XTX Topco's Amgen position peaked at $6.95M in Q1 2026.
  • 3,150 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.